Morning Briefing
Summaries of health policy coverage from major news organizations
Drug Companies Collaborate With DNDi Support To Develop Drug For African Sleeping Sickness
Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports (Leslie, 6/28).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
